Osaka, Japan

Jun-ichi Kunizaki

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jun-ichi Kunizaki: Innovator in Medical Measurement Technologies

Introduction

Jun-ichi Kunizaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical measurement technologies, particularly in assessing insulin resistance and energy malnutrition in liver disease patients. His innovative approaches have led to the development of several patents that enhance diagnostic methods in healthcare.

Latest Patents

Kunizaki holds 3 patents, with his latest inventions focusing on critical health measurements. One of his notable patents is a method for measuring insulin resistance using fatty acid combustion. This invention provides a systematic approach to assess insulin resistance in test subjects, utilizing a composition that includes a C-fatty acid labeled with isotopes. The process involves converting the fatty acid into labeled carbon dioxide, which is then exhaled. Another significant patent addresses energy malnutrition evaluation in liver disease patients. This method determines the nutritional state of liver disease subjects by analyzing expired air for labeled carbon dioxide generated from glucose labeled with isotopes.

Career Highlights

Kunizaki is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the medical field. His work has been instrumental in developing methods that improve patient care and diagnostic accuracy.

Collaborations

He collaborates with talented individuals such as Makoto Inada and Kazuki Tobita, who contribute to his research and development efforts.

Conclusion

Jun-ichi Kunizaki's contributions to medical measurement technologies exemplify the impact of innovative thinking in healthcare. His patents not only advance diagnostic methods but also enhance the understanding of critical health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…